-
Je něco špatně v tomto záznamu ?
Mouse model of focal cortical dysplasia type II generates a wide spectrum of high-frequency activities
J. Chvojka, N. Prochazkova, M. Rehorova, J. Kudlacek, S. Kylarova, M. Kralikova, P. Buran, R. Weissova, M. Balastik, JGR. Jefferys, O. Novak, P. Jiruska
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- elektroencefalografie MeSH
- epilepsie * MeSH
- fokální kortikální dysplazie * MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- TOR serin-threoninkinasy MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
High-frequency oscillations (HFOs) represent an electrographic biomarker of endogenous epileptogenicity and seizure-generating tissue that proved clinically useful in presurgical planning and delineating the resection area. In the neocortex, the clinical observations on HFOs are not sufficiently supported by experimental studies stemming from a lack of realistic neocortical epilepsy models that could provide an explanation of the pathophysiological substrates of neocortical HFOs. In this study, we explored pathological epileptiform network phenomena, particularly HFOs, in a highly realistic murine model of neocortical epilepsy due to focal cortical dysplasia (FCD) type II. FCD was induced in mice by the expression of the human pathogenic mTOR gene mutation during embryonic stages of brain development. Electrographic recordings from multiple cortical regions in freely moving animals with FCD and epilepsy demonstrated that the FCD lesion generates HFOs from all frequency ranges, i.e., gamma, ripples, and fast ripples up to 800 Hz. Gamma-ripples were recorded almost exclusively in FCD animals, while fast ripples occurred in controls as well, although at a lower rate. Gamma-ripple activity is particularly valuable for localizing the FCD lesion, surpassing the utility of fast ripples that were also observed in control animals, although at significantly lower rates. Propagating HFOs occurred outside the FCD, and the contralateral cortex also generated HFOs independently of the FCD, pointing to a wider FCD network dysfunction. Optogenetic activation of neurons carrying mTOR mutation and expressing Channelrhodopsin-2 evoked fast ripple oscillations that displayed spectral and morphological profiles analogous to spontaneous oscillations. This study brings experimental evidence that FCD type II generates pathological HFOs across all frequency bands and provides information about the spatiotemporal properties of each HFO subtype in FCD. The study shows that mutated neurons represent a functionally interconnected and active component of the FCD network, as they can induce interictal epileptiform phenomena and HFOs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007733
- 003
- CZ-PrNML
- 005
- 20240423160220.0
- 007
- ta
- 008
- 240412e20231217xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nbd.2023.106383 $2 doi
- 035 __
- $a (PubMed)38114051
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Chvojka, Jan $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
- 245 10
- $a Mouse model of focal cortical dysplasia type II generates a wide spectrum of high-frequency activities / $c J. Chvojka, N. Prochazkova, M. Rehorova, J. Kudlacek, S. Kylarova, M. Kralikova, P. Buran, R. Weissova, M. Balastik, JGR. Jefferys, O. Novak, P. Jiruska
- 520 9_
- $a High-frequency oscillations (HFOs) represent an electrographic biomarker of endogenous epileptogenicity and seizure-generating tissue that proved clinically useful in presurgical planning and delineating the resection area. In the neocortex, the clinical observations on HFOs are not sufficiently supported by experimental studies stemming from a lack of realistic neocortical epilepsy models that could provide an explanation of the pathophysiological substrates of neocortical HFOs. In this study, we explored pathological epileptiform network phenomena, particularly HFOs, in a highly realistic murine model of neocortical epilepsy due to focal cortical dysplasia (FCD) type II. FCD was induced in mice by the expression of the human pathogenic mTOR gene mutation during embryonic stages of brain development. Electrographic recordings from multiple cortical regions in freely moving animals with FCD and epilepsy demonstrated that the FCD lesion generates HFOs from all frequency ranges, i.e., gamma, ripples, and fast ripples up to 800 Hz. Gamma-ripples were recorded almost exclusively in FCD animals, while fast ripples occurred in controls as well, although at a lower rate. Gamma-ripple activity is particularly valuable for localizing the FCD lesion, surpassing the utility of fast ripples that were also observed in control animals, although at significantly lower rates. Propagating HFOs occurred outside the FCD, and the contralateral cortex also generated HFOs independently of the FCD, pointing to a wider FCD network dysfunction. Optogenetic activation of neurons carrying mTOR mutation and expressing Channelrhodopsin-2 evoked fast ripple oscillations that displayed spectral and morphological profiles analogous to spontaneous oscillations. This study brings experimental evidence that FCD type II generates pathological HFOs across all frequency bands and provides information about the spatiotemporal properties of each HFO subtype in FCD. The study shows that mutated neurons represent a functionally interconnected and active component of the FCD network, as they can induce interictal epileptiform phenomena and HFOs.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 12
- $a fokální kortikální dysplazie $7 D000092222
- 650 _2
- $a elektroencefalografie $7 D004569
- 650 12
- $a epilepsie $7 D004827
- 650 _2
- $a TOR serin-threoninkinasy $7 D058570
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Prochazkova, Natalie $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Rehorova, Monika $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kudlacek, Jan $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kylarova, Salome $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kralikova, Michaela $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Buran, Peter $u Laboratory of Molecular Neurobiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Weissova, Romana $u Laboratory of Molecular Neurobiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Balastik, Martin $u Laboratory of Molecular Neurobiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Jefferys, John G R $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Novak, Ondrej $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Jiruska, Premysl $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: premysl.jiruska@lfmotol.cuni.cz
- 773 0_
- $w MED00008403 $t Neurobiology of disease $x 1095-953X $g Roč. 190 (20231217), s. 106383
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38114051 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160217 $b ABA008
- 999 __
- $a ok $b bmc $g 2081612 $s 1217500
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 190 $c - $d 106383 $e 20231217 $i 1095-953X $m Neurobiology of disease $n Neurobiol Dis $x MED00008403
- LZP __
- $a Pubmed-20240412